Restrictions on Hydroxychloroquine Contribute to the COVID-19 Cases Surge

By Leo Goldstein – Re-Blogged From WUWT

[cr note: This is an interesting hypothesis from Leo Goldstein.  I’ll add some observations]

We have a sharp surge in the new COVID-19 cases. The main [or just one factor out of several, a contributor ~cr] cause is likely to be the drop in the use of Hydroxychloroquine based treatment, following the FDA Memorandum of June 15. The FDA Memorandum accompanied the revocation of the Emergency Use Authorization for Hydroxychloroquine and Chloroquine from the National Strategic Stockpile. The FDA Memorandum vilified the drug, falsely alleging that it is not safe and “unlikely to be effective” against COVID-19 – when thousands of doctors have treated hundreds of thousands of patients with it . The National Institutes of Health’s NIH COVID-19 Panel updated its Guidelines to match on the FDA’s opinion the next day.

Continue reading

New Paper Demonstrates Strong Efficacy of Hydroxychloroquine. Mortality rate cut in half!

Posted by Jeff Id – Re-Blogged From WUWT

Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19

A new study of over 2000 hospitalized patients reveals that Hydroxychloroquine works very well in treatment of COVID.  The reason I’m so excited about this one is because unlike the poor studies that I’ve written about already, this study controlled the dosages, use the correct levels of HCQ and Azythromycin per other studies, and matched patients to each other by their own health situations.  This matching of health condition is the proper method to control the confounding factors in a situation where testing cannot be double-blind.  The health of the patient is what the frustratingly fake studies didn’t correct for, but certain political pressures made them popular.

This is absolutely the most conclusive research produced to date by anyone, due mostly to the quality of the approach.  No one has published this quality level of work on HCQ on humans prior to this.

Continue reading

Distributed Denial of HCQ to COVID-19 Victims

Summary

On March 19, at a White House briefing, President Trump “touted” chloroquine (hydroxychloroquine is chloroquine metabolite) for possible use against COVID-19. The very next day, a media operation was launched to deny this treatment to the public. Several fake news outlets published articles, saying things like this (NYT, March 20):

Trump’s Embrace of Unproven Drugs to Treat Coronavirus Defies Science

Doctors and patients also worry that the president’s rosy outlook for the treatments will exacerbate shortages of old malaria drugs relied on by patients with lupus and other debilitating conditions.

Continue reading

Many Effects of Hydroxychloroquine Against COVID-19

By Leo Goldstein – Re-Blogged From WUWT

This is a scientific review, published to inform health care professionals and public officials, and for an open peer review. It is not medical advice.

Abstract

Hydroxycholoroquine (HCQ) is effective against COVID-19 in a variety of roles – the main two being antiviral and immunomodulator.  This “silver bullet” effect may have caused confusion between different effects. It is better to start HCQ-based treatment as early as possible.

Continue reading

Wuhan #coronavirus and CoVid-19—Rumination #8

By Rud Istvan – Re-Blogged From WUWT

There are as of today (5/1/2020) several newish developments enabling further skeptical comparisons to ‘climate science’. These involve post #4 on two possible therapies (remdesivir and the chloroquines), and post #7 on ivermectin. The bottom line is yet more contradictions and speculations, all reported without full disclosure. This post pulls a new overview together from public sources and from previous comments to other posts.

Remdesivir

Two initial clinical trials have been reported. The first was done in China using remdesivir synthesized there without regard to Gilead’s patent, and after China filed for a patent using remdesivir to treat CoViD-19. The second was done in the US by Gilead and reported midweek. The results contradict each other, sort of like modeled ECS versus observed ECS in climate science.

Continue reading

SD Gov. Winning Wuhan Flu Battle w/out Lockdown; Starts Hydroxychloroquine Trials

‘If a leader will take too much power in a time of crisis, that is how we lose our country…’

 1

Wikimedia Commons: South Dakota Gov. Kristi Noem

South Dakota Gov. Kristi Noem has simultaneously kept the state open, protected the liberties of her citizens, and started the first state-wide hydroxychloroquine clinical trials in the nation, all while winning the battle against the Wuhan flu.

Despite negative coverage from the corporate news media, Noem has resisted calls to shut down her state’s businesses, churches, hospitals, and schools, Fox News reported.

“The governor just lets this problem get bigger and bigger and bigger,” Sen. Elizabeth Warren said on “The Rachel Maddow Show.”

Noem has refused to subject South Dakota’s citizens to mass unemployment, which leads to substance abuse, suicide, poverty, and other health issues.. Continue reading